Mendelian randomization and nomogram-based prediction of hepatocellular carcinoma risk in patients with hepatitis B cirrhosis

Background To innovatively integrate genetic causality and multidimensional clinical indicators, we aimed to investigate causal relationships between metabolic-inflammatory biomarkers and hepatocellular carcinoma (HCC) risk in hepatitis B-related cirrhosis (HBV-C) using Mendelian randomization (MR),...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xiaolong Zheng, Yiping Hong, Wei Wei
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	PeerJ Inc. 2025-10-01
Edice:	PeerJ
Témata:	Hepatitis B-related cirrhosis Hepatocellular carcinoma Clinical indicators Nomogram Mendelian randomization
On-line přístup:	https://peerj.com/articles/20179.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!